Detalhe da pesquisa
1.
IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma.
Allergy;
78(1): 156-167, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35986608
2.
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
J Allergy Clin Immunol;
149(1): 89-101, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33891981
3.
An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells.
Clin Exp Pharmacol Physiol;
44(9): 932-940, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28508433
4.
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.
BMC Pulm Med;
15: 91, 2015 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26286141
5.
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice.
ERJ Open Res;
7(2)2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34109236
6.
Patient and healthcare professional experiences of the Salford Lung Studies: qualitative insights for future effectiveness trials.
Trials;
21(1): 798, 2020 Sep 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32943093
7.
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design.
ERJ Open Res;
5(4)2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31720293
8.
Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle.
Int J Chron Obstruct Pulmon Dis;
12: 1903-1913, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28721035
9.
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
J Clin Epidemiol;
89: 173-180, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28502808
10.
Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection.
J Clin Epidemiol;
88: 14-20, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28502811
11.
Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
Int J Chron Obstruct Pulmon Dis;
11: 2885-2895, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27932872
12.
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
Respir Med;
109(7): 870-81, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26006754
13.
Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
Ann N Y Acad Sci;
1280: 35-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23551101